Clinical Trials Logo

Coronary Disease clinical trials

View clinical trials related to Coronary Disease.

Filter by:

NCT ID: NCT06009757 Not yet recruiting - Clinical trials for Coronary Artery Disease

GUIDEX® Versus Launcherâ„¢ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR)

GUIDEX®_FR
Start date: February 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare two guiding catheters in patients with coronary artery disease during a percutaneous coronary intervention between Guidex® Guiding catheter (DEMAX) and Launcherâ„¢ coronary guide catheters (Medtronic). The main question[s] it aims to answer are: - Aren't the safety of medical devices inferior to each other? - Aren't the efficacyof medical devices inferior to each other? Participants will be randomized (1:1) and have a percutaneous coronary interventionwith one of the two guiding catheters.

NCT ID: NCT06008041 Active, not recruiting - Clinical trials for Coronary Artery Disease

Multimodal Epicardial and Endocardial COronary PHYsiological Evaluation in Pathological Situations (PHYCO)

PHYCO
Start date: July 13, 2023
Phase:
Study type: Observational

When performing coronary angiography in a stable situation, the identification of an intermediate coronary lesion (between 50 and 70%) is common, and requires additional functional evaluation. The gold standard for this evaluation is Fractional Flow Reserve (FFR). FFR is a flow ratio transformed into a pressure ratio by simplification, neglecting some parameters, especially microcirculatory resistance. The aim of this study is to investigate hemodynamic and structural assessment induced in specific conditions, and their repercussion on functional assessment by FFR to implement the diagnostic approach and personalize it for each patient.

NCT ID: NCT06007248 Not yet recruiting - Clinical trials for Coronary Artery Disease

Disease Characteristics of IR-CAD: a Case-control Study

Start date: August 2023
Phase:
Study type: Observational

The present case-control study is designed to investigate the disease characteristics of IR-CAD by comparing the demographics, clinical features, lab results, imaging findings, and prior treatment between 20 patients with IR-CAD and 10 patients with AS-CAD.

NCT ID: NCT06002932 Recruiting - Clinical trials for Coronary Artery Disease

Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.

PROVISIONDEB
Start date: September 8, 2023
Phase: N/A
Study type: Interventional

[The Purpose of the Clinical Study] The purpose of this randomized comparison study is to compare the 1-stent strategy with a drug-eluting balloon and the 2-stent strategy in patients with non-LM coronary true-bifurcation lesions. [Hypothesis] In this study, the researchers intend to verify the hypothesis that the 1-stent strategy with a drug-eluting balloon is non-inferior to the 2-stent strategy in terms of target lesion failures (cardiac death, target vessel MI, or target vessel revascularization).

NCT ID: NCT06000540 Not yet recruiting - Clinical trials for Coronary Artery Disease

Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects

NIMO-Healthy
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

This is a prospective pilot study to evaluate the safety, tolerability and efficacy of utilizing precise computer controlled gas challenge in healthy subjects for identification of coronary artery disease.

NCT ID: NCT05997693 Not yet recruiting - Clinical trials for Chronic Coronary Disease

One-Month DAPT in CABG Patients

ODIN
Start date: October 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with chronic coronary disease undergoing coronary artery bypass grafting.

NCT ID: NCT05984953 Completed - Clinical trials for Coronary Artery Disease

Rosuvastatin and Evolocumab for Coronary Artery Disease

Yellow V
Start date: August 1, 2013
Phase:
Study type: Observational

The aim of the retrospective study is to characterize the molecular mechanisms responsible for the effect of statins and evolocumab in patients with stable coronary artery disease. The research team will retrieve and review intravascular imaging and gene expression data previously collected in the catheterization laboratory during the following time-period: 8/1/2013-4/14/2015 and 5/4/2021 - 10/28/2022.

NCT ID: NCT05981911 Recruiting - Clinical trials for Coronary Artery Disease

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

IRIS Skypoint
Start date: December 30, 2023
Phase:
Study type: Observational

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

NCT ID: NCT05980364 Completed - Clinical trials for Have a Diagnosis of Coronary Artery Disease

Cardiac Rehabilitation in Coronary Artery Diseases

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

Cardiac rehabilitation is approaches that focus on accelerating the recovery process of patients after a cardiac event, improving their physical, psychological and social conditions, and controlling risk factors. Cardiac rehabilitation is known to be an effective and cost-effective approach in the secondary prevention of cardiovascular diseases, most of which are caused by preventable risks. Ischemic heart diseases, one of the cardiovascular diseases, are responsible for 16% of total deaths in the world and have increased significantly since 2000, causing 8.9 million deaths in 2019. When coronary artery diseases cannot be prevented, the basic approach should be to ensure the individual's compliance with treatment and healthy lifestyle behaviors, and to increase the quality of life and life span. For this reason, the aim of the study is to examine the effects of technology-based education structured according to the health promotion model in cardiac rehabilitation on healthy lifestyle behaviors, health fatalism and risk knowledge level. Question 1. Does technology-based education structured according to the health promotion model affect the healthy lifestyle behaviors score? Question 2. Does technology-based education structured according to the health promotion model affect the health fatalism score? Question 3. Does technology-based education structured according to the health promotion model affect the cardiovascular disease risk factors knowledge level score?

NCT ID: NCT05978726 Completed - Clinical trials for Coronary Heart Disease

Ticagrelor Versus Clopidogrel for CMD in Patients With AMI: A Retrospective Study Based on the Angio-IMR

Start date: July 1, 2017
Phase:
Study type: Observational

Coronary microvascular dysfunction (CMD) is increasingly recognized as an important indicator for long-term prognosis in patients with acute myocardial infarction (AMI). The angiography-derived index of microcirculatory resistance (angio-IMR) is a novel guidewire-free measure for CMD in patients with AMI. Ticagrelor has recently been suggested to have additional benefits on coronary microcirculation beyond its antiplatelet effect. This study was designed to compare the protective effects of ticagrelor and clopidogrel on CMD and prognostic impact in patients with AMI, using the angio-IMR as a novel assessment tool.